Drug Trial News

RSS

ZARS starts phase 3 trial of ThermoProfen

ZARS, Inc., has announced that it commenced the first of two Phase 3 clinical trials of ThermoProfen in patients with mild to moderate osteoarthritis (OA) of the knee on June 26, 2007.

26 Jul 2007

White blood cell booster may help cancer patients avoid deadly complications

Cancer patients who receive a drug that stimulates the growth of infection-fighting white blood cells may be significantly less likely to die from a chemotherapy-related complication characterized by fever and low white blood cell levels, according to a multi-institutional study led by researchers from the University of Rochester School of Medicine and Dentistry and the Duke University Comprehensive Cancer Center.

26 Jul 2007

Children with HIV early antiretroviral therapy study

Hundreds of thousands of babies around the world are born each year with HIV--more than half a million in 2006 alone.

26 Jul 2007

New hope for aortic dissection survivors

Each year, 10,000 Americans suffer a sudden tear in the lining of their body's largest blood vessel, the aorta.

26 Jul 2007

Steroid medications don't work in treating lower respiratory infections in children

The use of steroid medication to treat bronchiolitis, a common viral lower respiratory infection in infants , does not prevent hospitalization or improve their respiratory symptoms, according to a study published in the July 26 issue of The New England Journal of Medicine.

26 Jul 2007

Resisting peer pressure all in the brain

The capacity to resist peer pressure in early adolescence may depend on the strength of connections between certain areas of the brain, according to a study carried out by University of Nottingham researchers.

26 Jul 2007

Metformin gets top grade for diabetes

A type 2 diabetes drug taken orally and in widespread use for more than a decade has been found to have distinct advantages over nine other, mostly newer medications used to control the chronic disease, according to a study by researchers at Johns Hopkins.

26 Jul 2007

Are your friends making you fat? Or keeping you slender?

According to new research from Harvard and the University of California, San Diego, the short answer on both counts is "yes."

26 Jul 2007

Obesity spreads within social networks

People wondering about excessive weight gain might look to their relationships with family and friends for one clue, suggests new research reported July 26, 2007, in The New England Journal of Medicine.

26 Jul 2007

PA catheterization uses decreases substantially in U.S.

Use of the pulmonary artery catheter decreased by 65 percent in the U.S. between 1993 and 2004, possibly due to growing evidence that this invasive procedure does not reduce the risk of death for hospitalized patients, according to a study in the July 25 issue of JAMA .

25 Jul 2007

$Hip protectors do not reduce risk of hip fracture for nursing home residents$

Hip protectors do not reduce risk of hip fracture for nursing home residents

Use of an energy-absorbing hip protector did not provide a protective effect against hip fracture for nursing home residents, adding to increasing evidence that hip protectors, as currently designed, are not effective for preventing hip fractures, according to a study in the July 25 issue of JAMA.

25 Jul 2007

Implantable contraceptives are extremely effective

Although the devices are barely used in developed countries and only a bit more popular elsewhere, a new review of research suggests that implantable contraceptives are extremely effective.

25 Jul 2007

Radiation therapy combined with microsurgery shows promise for curing injured spinal cord

Research on rats with crushed spinal cords, similar to human injury, reveals that treatment soon after injury combining radiation therapy to destroy harmful cells and microsurgery to drain excess fluids significantly increases the body's ability to repair the injured cord leading to permanent recovery from injury, according to the study published in the July 18 peer-reviewed journal PLoS ONE.

25 Jul 2007

Prenatal alcohol exposure alters brain activity in the frontal-striatal areas

Heavy prenatal alcohol exposure does not always lead to fetal alcohol syndrome (FAS); sometimes it can lead to cognitive and behavioral deficits in the absence of craniofacial features needed to make an FAS diagnosis.

25 Jul 2007

Telephone counseling coaxes reluctant alcoholics into treatment

Telephone counseling might be an effective primary care intervention for men who are not seeking treatment for their alcohol dependence or abuse, according to a new study.

25 Jul 2007

Guilt plays a vital role in the regulation of social behavior

That worried feeling in our gut often serves as the impetus for our stab at redemption. However, psychologists have trouble agreeing on the function of this complex emotion.

25 Jul 2007

Genetic susceptibility to diet-induced obesity

Researchers at the Monell Chemical Senses Center have identified a genetically-transmitted metabolic defect that can lead to obesity in some individuals.

25 Jul 2007

Implantable cardioverter-defibrillator effective in preventing sudden cardiac death in patients with hypertrophic cardiomyopathy

High-risk patients with hypertrophic cardiomyopathy appear to have reduced risk of sudden cardiac death with an implantable cardioverter-defibrillator that terminates dangerous heart rhythm disorders, according to a study in the July 25 issue of JAMA.

25 Jul 2007

FDA advisory committee recommends that FDA wait for overall survival results from Satraplatin phase 3 trial

GPC Biotech AG has announced that the Oncologic Drugs Advisory Committee (ODAC) for the U.S. Food and Drug Administration (FDA) recommended (12-0) that the FDA should wait for the final survival analysis of the SPARC trial before deciding whether the satraplatin application is approvable for the treatment of hormone-refractory prostate cancer patients whose prior chemotherapy has failed.

25 Jul 2007

Faster-acting antidepressant medications

A new study has revealed more about how the medication ketamine, when used experimentally for depression, relieves symptoms of the disorder in hours instead of the weeks or months it takes for current antidepressants to work.

25 Jul 2007